The invention refers to the use of compositions/ formulations based on a mixture of lactoferrin and apolactoferrin for the treatment of diseases characterized by iron accumulation, preferably for topical use. Said formulations can be used in food, cosmetic, cosmeceutic, dermatologic or pharmaceutical fields and are particularly suited for the treatment of ecchymotic pigmentations and skin dyschromias in general.